Qube Research & Technologies (QRT)’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
Qube Research & Technologies (QRT)'s TVRD Position: Q3 2026 in Review
Qube Research & Technologies (QRT) sold out of Tvardi Therapeutics (TVRD) in Q3 2026, closing a stake of 10,210 shares — an estimated $19.4K sold.
Qube Research & Technologies (QRT) first reported a position in TVRD in Q1 2022 and held it in 9 quarters. The position peaked at $690K in Q2 2022. 62 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.
- Qube Research & Technologies (QRT) reported no remaining Tvardi Therapeutics position as of Q3 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 10,210 Tvardi Therapeutics shares in Q3 2026, an estimated $19.4K.
- Qube Research & Technologies (QRT) first reported a position in Tvardi Therapeutics in Q1 2022 and held it in 9 quarters.
- Qube Research & Technologies (QRT)'s Tvardi Therapeutics position peaked at $690K in Q2 2022.
- 62 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.